Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Breast Neoplasms 21Motor Activity 5Lymphedema 3Uterine Cervical Neoplasms 2Signs and Symptoms 2Osteoporosis, Postmenopausal 2Fatigue 2Weight Loss 1Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Invasive Breast Carcinoma 1Inflammation 1Colorectal Neoplasms 1Breast Cancer Lymphedema 1

Interventions

pembrolizumab 2Trastuzumab 2Magnetic Resonance Spectroscopy 2Immunoglobulin G 2Fulvestrant 2ulixertinib 1tucatinib 1trastuzumab biosimilar HLX02 1trametinib 1seribantumab 1sapanisertib 1relatlimab 1pertuzumab 1palbociclib 1osimertinib 1omipalisib 1larotrectinib 1ipatasertib 1erdafitinib 1durvalumab 1defactinib 1dabrafenib 1copanlisib 1cemiplimab 1capivasertib 1binimetinib 1adavosertib 1X-Rays 1Sunitinib 1Specimen Handling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Neoplasms × Resistance Training × Breast × Clear all
NCT01709175 2015-06-08

Strength Training Study for Survivors of Breast and Gynecologic Cancer

Nova Scotia Health Authority

Phase NA Completed
20 enrolled
BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Fatigue, Motor Activity, Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡